A universal CAR-T cell that expresses an Fc-gamma receptor (FcγR)-CAR such as CD16A158F and CD32A131R CARs has been generated, using multiple therapeutic antibodies to redirect T cells to antigen-expressing tumor cells including EGFR-overexpressing TNBC (114, 115). The gene discussed is EGFR; the disease is neoplasm.